Let’s cut to the chase: erectile dysfunction (ED) is a common issue, but it’s not the end of the world. Not even on Valentine ...

Dr. Margaret Carpenter, her company Nightingale Medical, PC, and an unnamed third person have all been charged with “criminal ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

6- World Health Organisation encourages prescribing by generic name. Drug Regulatory Authority of Pakistan has issued a ...

Academic detailing interventions significantly improved more than half of evidence-based prescribing outcomes.

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective product.

NSDUH only queried opioid misusers about opioid use disorder symptoms. After they changed the protocol and asked all ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

Perhaps no issue has devastated our public health more over the last 25 years than the opioid crisis. Thankfully, there are ...